Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
| Open | 18.98 | Prev Close | 19.01 |
| High | 19.13 | Low | 18.22 |
| Volume | 2,260,086 | Volume (Avg) | 3,167 |
| 52 Week High | 20.54 | 52 Week Low | 9.93 |
| Market Cap | 2.5B | PE Ratio | 10.67 |
General
| Name | Upwork Inc |
| Ticker | UPWK |
| Exchange | NASDAQ |
| Sector | Communication Services |
| Industry | Internet Content & Information |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 600 |
About Upwork Inc
Upwork Inc., together with its subsidiaries, operates a work marketplace that connects businesses with various independent professionals and agencies in the United States, India, the Philippines, and internationally. The company's work marketplace provides access to talent with various skills across a range of categories, including administrative support, sales and marketing, design and creative, and customer service, as well as web, mobile, and software development. Its work marketplace also enables clients to streamline workflows, such as talent sourcing, outreach, and contracting. The company's work marketplace offers access to various functionalities for remote engagements with talent, including communication and collaboration, ability to receive talent invoices through their work marketplace, and payment protection. Its marketplace offerings include Upwork Payroll, enterprise, managed, and escrow services. The company was formerly known as Elance-oDesk, Inc. and changed its name to Upwork Inc. in May 2015. Upwork Inc. was incorporated in 2013 and is headquartered in Palo Alto, California.
Highlights
| Analyst Target | 19.90 |
| Market Cap | 2,462,500,000 |
| PE Ratio | 10.67 |
| PEG Ratio | 0.98 |
| EBITDA | 131,529,000 |
Valuation
| Trailing PE | 11.12 |
| Forward PE | 14.39 |
| Price/Sales (Trailing 12 Mt.) | 3.29 |
| Price/Book (Most Recent Quarter) | 4.17 |
Technicals
| Beta | 1.54 |
| 52 Week High | 20.54 |
| 52 Week Low | 9.93 |
| 50 Day Average | 21.16% |
| 200 Day Average | 24.13% |
Earnings
Patrick Zalupski's group closes on its purchase of the Tampa Bay Rays
NEW YORK (AP) — A group led by Florida-based real estate developer Patrick Zalupski closed on its purchase of the Tampa Bay Rays on Tuesday, finalizing the sale of the team from former owner Stuart Sternberg.
Nvidia Smashes 52-Week High As Robots And AI Take Off
Nvidia (NASDAQ: NVDA) leads the AI revolution, hitting a $4.5T market cap. Citigroup forecasts Big Tech to invest $2.8T in AI infra by 2029.
FDA Approval Could Send This Stock Soaring - Ad
Whenever the FDA approves a new drug... Timely investors could see 300-400% returns... ChemoCentryx soared 281% in the year after it won FDA approval... Immunogen jumped 449% in the two years after it won FDA approval... Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did.
US government is phasing out paper checks. Here's what that means for you
WASHINGTON (AP) — The U.S. government starts phasing out for most programs on Tuesday.
Mexico proposes new import taxes on 1,400 products to boost national production
MEXICO CITY (AP) — Mexico’s government submitted a budget proposal Tuesday that would impose new import taxes on more than 1,400 products — many from Asian nations — to strengthen national production at a time when the United States is pressuring its North American trade partner to .
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Ben & Jerry's Co-Founder Resigns In Protest As Politics Continue To Influence Corporate Exits
Jerry Greenfield, of Ben & Jerry's fame, didn't resign over personal controversy—he quit because his company stopped being political enough.
Fed convenes meeting with a governor newly appointed by Trump and another he wants to oust
WASHINGTON (AP) — After a and the Federal Reserve began a key meeting on interest rate policy Tuesday with both a new Trump administration appointee and an official the White House has targeted for removal.
The Next Evolution in Public Treasuries - Ad
MicroStrategy proved the model with BTC. Now a NASDAQ-listed firm is running it with BNB, yield, and 290M users. $368M locked in.
It's 'do or die' for electric vehicle maker Rivian as it breaks ground on a $5 billion plant
ATLANTA (AP) — It seems like a terrible time to build an electric vehicle plant in the United States, but Rivian Automotive leaders say they're confident as the company starts on a $5 billion facility in Georgia.
Apple's iPhone 17 Series Takes Off, Meta's New Smart Glasses And Major Partnerships In AI Space: This Week In AI
This weekend's tech roundup featured Apple's strong iPhone 17 launch in China and India, Meta's new smart glasses, major AI partnerships like Intel-Nvidia and PayPal-Google, and Jim Cramer questioning Huawei's chip breakthrough.
We've Seen This Before... and It Didn't End Well - Ad
Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.
Donald Trump Declares Harsh Media Coverage of Him 'No Longer Free Speech' But 'Illegal'
President Donald Trump has labeled negative media coverage of him as "illegal."
Cathie Wood Loads Up On Bullish Inc, Pony AI And Robinhood — Dumps Kratos Defense Amid Taiwan Drone Buzz
On Sept 17, 2025, Cathie Wood-led Ark Invest executed significant trades involving Bullish, Kratos Defense, Pony AI, and Robinhood. These reflect Ark's focus on emerging tech and defense sectors.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Many sports fans are unhappy with how much it costs to watch their games, an AP-NORC poll finds
WASHINGTON (AP) — For many dedicated sports fans, keeping up with their favorite teams has become a juggling act.
FDA proposes ban on Orange B, a food dye not used for decades
Federal regulators are proposing to remove another from the U.S. food supply — Orange B, a synthetic color that hasn't been used in the U.S. for decades.
Digital Gold. Digital Oil. Digital Infrastructure. - Ad
Bitcoin and Ethereum had their turn. Now a NASDAQ-listed firm is scaling BNB, which fuels 290M users and pays yield.
Appeals court rejects Trump's bid to unseat Federal Reserve governor Lisa Cook ahead of rate vote
WASHINGTON (AP) — An appeals court ruled Monday that can remain a Federal Reserve governor, rebuffing President Donald Trump’s efforts to remove her just ahead of a key vote on interest rates.
Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients
Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.
The First Public Cash-Flowing Digital Treasury - Ad
Unlike Bitcoin vaults, this NASDAQ-listed company earns yield through BNB staking and nodes. $368M already deployed, still overlooked.
Republicans unveil a bill to fund the government through Nov. 21. Democrats call it partisan
WASHINGTON (AP) — House Republicans unveiled Tuesday a stopgap spending bill that would keep federal agencies funded through Nov. 21, daring Democrats to block it knowing that the fallout would likely be a partial government shutdown that would begin Oct. 1, the start of the new budget year.
Anthropic's $1.5 Billion Settlement Over AI Training On Pirated Books Sets Precedent As Lawsuits Against OpenAI, Meta Loom
A federal judge in California has given preliminary approval to Amazon.com Inc. (NASDAQ: AMZN) and Alphabet Inc.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Fallout from cyberattack on check-in systems at 3 European airports continues for 2nd day
BRUSSELS (AP) — Fallout from a cyberattack that affected check-in systems at several European airports extended into a second full day on Sunday, as passengers faced dozens of cancelled and delayed flights and airport teams scrambled to limit the damage to travel plans.
Family says a man who died after going on a Universal roller coaster never let wheelchair stop him
ORLANDO, Fla. (AP) — A 32-year-old man who from blunt impact injuries after going on a roller coaster at Universal Orlando Resort’s newest park used a wheelchair. But his family said it never stopped his unwavering spirit.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
AP Exclusive: Russia, Vietnam using energy profits to avoid possible US sanctions for arms deals
BANGKOK (AP) — Russia and Vietnam have developed a back-door method of concealing arms deal payments to avoid American and other Western sanctions, using the profits from joint oil and gas ventures to pay off defense contracts without any open transfers of cash through the global banking system, according to internal Vietnamese documents obtained by The Associated Press.
European Central Bank expected to keep rates on hold as economy weathers Trump's tariffs
FRANKFURT, Germany (AP) — Inflation is back under control, and the European economy is weathering Trump's tariff onslaught better than expected. Those are reasons the European Central Bank is expected to keep its benchmark interest rate unchanged Thursday.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Elon Musk's xAI Reportedly Lays Off 500 Workers From Data Annotation Team As Startup Pivots To Specialist AI Tutors For Grok Expansion
Elon Musk's xAI has laid off about 500 data annotators in a major restructuring, shifting focus to specialist AI tutors to accelerate Grok's development despite recently securing $10 billion in new funding.
Europe's Ryder Cup team uses VR headsets to prepare for noise and insults at Bethpage Black
VIRGINIA WATER, England (AP) — Whatever heckling European players might face at the Ryder Cup in New York could be what they already have heard before, all because of virtual reality headsets that Rory McIlroy says can be adjusted to hear the harshest abuse.
FDA Approval Could Send This Stock Soaring - Ad
Whenever the FDA approves a new drug... Timely investors could see 300-400% returns... ChemoCentryx soared 281% in the year after it won FDA approval... Immunogen jumped 449% in the two years after it won FDA approval... Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did.
Nio, Rivian, Moderna, Meta And Bitmine Immersion: Why These 5 Stocks Are On Investors' Radars Today
On Tuesday, U.S. markets slipped, with the Dow Jones Industrial Average falling about 0.3% to 45,757.90, the S&P 500 retreating 0.1% to 6,606.76, and the Nasdaq edging down 0.07% to 22,333.96.These are the top stocks that gained the attention of retail traders and investors throughout the day.
Cracker Barrel, D-Wave Quantum, IonQ, Krispy Kreme And Broadcom: Why These 5 Stocks Are On Investors' Radars Today
On Wednesday, U.S. stocks closed mixed as the Dow Jones Industrial Average advanced 0.6% to 46,018.32.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
3 members of federal control board in Puerto Rico sue Trump and others for illegal firings
SAN JUAN, Puerto Rico (AP) — Three members of a federal control board overseeing Puerto Rico’s finances, by the administration of U.S. President Donald Trump, filed a lawsuit in federal court on Thursday alleging their firings were illegal.
Rigetti Computing Stock Soars On $5.8 Million Air Force Contract
Rigetti Computing Inc (NASDAQ:RGTI) shares are gaining traction on Thursday after the company announced a major quantum networking contract.
The Next Evolution in Public Treasuries - Ad
MicroStrategy proved the model with BTC. Now a NASDAQ-listed firm is running it with BNB, yield, and 290M users. $368M locked in.
Lam Research And JSR Resolve Legal Disputes As They Team Up On AI Era Chips
Lam Research and JSR Corp agreed to collaborate and cross-license, combining their expertise to accelerate semiconductor manufacturing and reduce costs.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.